feed,title,long_url,short_url
Benzinga,AbbVie's Upadacitinib Hits Primary Goal In Induction Study In Patients With Crohn's Disease,https://benzinga.com/general/biotech/21/12/24464104/abbvies-upadacitinib-hits-primary-goal-in-induction-study-in-patients-with-crohns-disease,https://j.mp/3dpOeLv
